IONS — IONIS PHARMACEUTICALS INC

Ownership history in Future Fund LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Future Fund LLC reported a position in IONIS PHARMACEUTICALS INC (IONS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.15% (2025 Q4)
Avg. % of fund
0.83%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 45,851 +9,695 +26.8% 1.15% $3.6M $79.11
2025 Q3 ADDED 36,156 +6,561 +22.2% 0.83% $2.4M $65.42
2025 Q2 INITIATED 29,595 — — 0.52% $1.2M $39.51
% of Fund (quarterly)    IONS price (monthly, adj. close)

Other funds also holding IONS

As of 2025 Q4 — sorted by position size

Tweedy, Browne Co LLC 3Y 7Y 15.74% BOONE CAPITAL MANAGEMENT LLC 3Y 10.37% Bellevue Group AG 3Y 7Y 7.2% Tri Locum Partners LP 3Y 5.72% Orion Investment Co 5.43% Exome Asset Management LLC 4.41% Privium Fund Management B.V. 3Y 3.51% Sicart Associates LLC 3Y 7Y 3.43% SECTOR GAMMA AS 3Y 7Y 3.34% SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 3Y 7Y 2.41%
← Back to Future Fund LLC Holdings